$Pistol Pete$, $Mick$ & Friends Stock Picks /news, DD and charts

[mick]

U.S. Companies Race To Catch Up In Coronavirus Tests
FacebookTwitterLinkedInShare Licensing
ALLISON GATLIN02:08 PM ET 03/20/2020
The U.S. faces an uphill battle against the coronavirus and the reason is simple: There aren't nearly enough coronavirus tests to identify who has Covid-19 and where resources are most needed.

https://www.investors.com/news/technology/coronavirus-tests-lagged-companies-racing-to-fix/?src=A00220&yptr=yahoo

Now, after a slow and bumpy start, the race is on to deliver coronavirus tests across the U.S. in volume. In the last eight days, nine medical product companies have won the Food and Drug Administration's blessing for patient tests using unapproved products. Before then, two government agencies held the only such emergency use authorizations, or EUAs, to peddle unapproved products to mass
The tests already are rolling out and should increase in volume soon, although the companies are not disclosing the production volumes. Some of the companies already were distributing tests in other countries.

The companies and government agencies using the federally sanctioned emergency protocol to roll out coronavirus tests are:

GenMark Diagnostics (GNMK), approved March 19
DiaSorin Molecular, approved March 19
Abbott Laboratories (ABT), approved March 18
Quest Diagnostics (DGX), approved March 17
Quidel (QDEL), also approved March 17
Laboratory Corp. of America (LH) , approved March 16
Hologic (HOLX), also approved March 16
Thermo Fisher Scientific (TMO), approved March 13
Roche (RHHBY), approved March 12
Wadsworth Center, New York State Department of Public Health, approved Feb. 29
Centers for Disease Control and Prevention, approved Feb. 4